Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where are you seeing that? We'll know in 5 minutes anyway.
Does anyone actually take Zacks seriously? I don't.
I love the progress this company is making.
They are part of the conversation, sure, but their analysts shoot darts blindfolded most of the time - especially with companies like this, on OTC.
I'm mentally prepared for earnings to be low and the stock price to take a small hit, but not a major one.
I'm also prepared for expected earnings and shares to drop a little bit.
There is nothing rational about this company's stock price until it gets up to the big board.
Hopefully I'm wrong on all fronts.
Hope for the best and prepare for the worst.
Bought more this morning.
NEWS: CVSI announces expanded Kroger distribution
https://ir.cvsciences.com/press-releases/detail/123/cv-sciences-inc-announces-expanded-distribution
CV SCIENCES, INC. ANNOUNCES EXPANDED DISTRIBUTION PARTNERSHIP WITH THE KROGER CO.
SAN DIEGO, July 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announce further expansion of its industry-dominating PlusCBD™ Oil brand with The Kroger Co.
CV Sciences’ expansion broadens distribution and availability of the Company’s best-selling PlusCBD™ Oil Original and Extra Strength Balms, and recently launched PlusCBD™ Oil Roll-Ons to more than 400 Kroger stores in five new states, including Georgia, Montana, Texas, Utah and Virginia. This expansion brings CV Sciences’ PlusCBD™ Oil distribution with Kroger to 22 states and 1,350 stores across many of Kroger’s retail banners, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths.
“We are pleased to further grow our distribution with Kroger and increase the availability of PlusCBD™ Oil products to more Kroger shoppers across the U.S.,” said Joseph Dowling, Chief Executive Officer. “We see significant opportunities to further expand our partnership into more Kroger retail outlets with additional product SKUs as demand for high quality, safe and effective hemp CBD products continues to increase with broader market acceptance.”
PlusCBD™ Oil Extra Strength Balm ranks #1 in sales in both the Total U.S. Natural Channel and Total U.S. MULO (Multi Outlet) over the last 52 weeks* among hemp CBD products within Topical Analgesics, according to SPINS and IRI data, respectively. Brightfield Group, a leading predictive analytics and market research firm for the CBD market, expects $1.3 billion in sales of hemp CBD topicals in 2019, with a compound annual growth rate of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
CONTACT INFORMATION:
Investor Contact:
ICR
Scott Van Winkle
617-956-6736
scott.vanwinkle@icrinc.com
Media Contact:
ICR
Cory Ziskind
646-277-1232
cory.ziskind@icrinc.com
*SPINS and IRI MULO scan data, 13 quad weeks ending April 21, 2019
I'm dubious on what they will be. Each quarter they don't live up to our expectations even though they still do show growth.
However, we need some really good Q on Q growth, from last Q.
Small money. I know people on this board that have more than some of these players.
Here's the link: https://finance.yahoo.com/quote/CVSI/holders/
CVSI is on the OTC - that's why it's down and there's no logic to its movement. OTC is a playground that is unstable, volatile and not taken seriously by the big players on the street.
If everyone seriously has to keep asking the same question "Why is it down" on this board, just sell because you have no idea how to invest in various exchanges.
Traders know OTC is volatile which is why they play hard here - tons of opportunity for them -- and long investors know there is a lot of potential in some OTC companies which is why they invest here with a long outlook, looking past the volatility and non-sensical movements. Long investors also know if they put money into the OTC, they should be ready to lose a lot of it because crazy stuff happens on the OTC - it's hardly regulated at all.
The forces that keep established NYSE, NASDAQ stocks stable and relatively (key word here) predictable, are not present on OTC.
BOTH traders and investors know that the trading, volume, and patterns in OTC stocks rarely make sense compared to the big exchanges.
So STOP asking the same questions - it just shows ignorance.
Just pick - which are you? A trader or an investor?
But for pete's sake, STOP asking the same stupid question.
Article: Senator Urges FDA To Speed Up CBD Regulations
https://www.marijuanamoment.net/senator-urges-fda-to-speed-up-cbd-regulations
I bought more this week. If we are down at these levels next week, I'll buy even more.
I agree with mc73 - this stock will explode at some point. Maybe not next week, but those who are real investors (not traders) will reap the rewards on this one, in my personal opinion.
If it hits 3.50 I'll definitely buy more and 3.15 a TON more. I'm a fundamental investor that holds multi-year. Don't say "ridiculous" - it's an opportunity.
You should turn your M&A musings into an opinion article for one of the industry websites. They would probably welcome the free content and your musings would add some nice common-sense speculation.
You string together some relatively cogent thoughts. If you want to bat it around, just email me at cvsitracker@gmail.com.
Step 1: Write the article keeping it to 400-800 words, and hyperlink to sources when you can - it adds validity and proves to the publication that you know what you are doing.
Step 2: Email some of the more well known industry blogs. Start with the most trafficked. You can evaluate which is the largest by plugging their URL into www.alexa.com/siteinfo
But only email them one at a time, not all at once. Sites will generally only publish an exclusive op-ed to only them. They won't run it if another site is running it.
Step 3: One of them will publish it and we all help circulate it around.
Bought more this morning. I keep saying I won't go more into this company because my portfolio is overweight in it but at sub $4.00 it's impossible to resist.
It's only a loss if you sell. You don't understand investing, trader. Go trade.
Only naive inexperienced people talk about gain and loss on day to day price while separating those words from actual selling and buying.
A "long" is minimum 365 days or intent to hold at least 365 days. Keep babbling, trader. Quick run to your bloomberg (if you even have one) and freak out about all kinds of moves in your other positions. Hurry! Run! Get anxious! Try to influence others on message boards! What you do must be so rewarding.
Maybe pain for you. I'm a long-term investor - that's how I invest in all things. This thing can go to $2.00 and I'll keep buying more. Maybe pain in your world, which is trader, anxiety, up and down, 'claiming to be a big shot but really not' world.
Keep babbling. I'll keep checking in here once a week or so, buying shares.
I'm long and have been buying consistently the past week. Let the traders trade, they are small ball. Actual investing is where the wealth is. These traders are all the same, small ball, small money, anxious driven blather. They don't have the discipline to invest to create real wealth. Instead they freak out every day on moves.
This is a great case study - albeit, a different scenario.
We won't see anything like this unless we move to NASDAQ. Wish we would but it could very well be 3-8 months until FDA clears things up and there is more clarity on all the guidelines and legal situations.
Agree with you. This stock is going to do nothing and is range bound until one of the big catalysts happen. All the daily chatter and wishful thinking is meaningless.
I'm in this for the next 1-5 years. I'm patient.
I saw this CNBC segment yesterday too. As simply a contributor, Scott has no control over what images CNBC shows on the screen. Some segment producer, most likely under 30 years old, behind the scenes has images they pick from that they've acquired the rights to use. Once they have a bank of images, they generally will go to those repeatedly for ease of use and speed when putting together the segment.
Highly doubtful Scott has any input on what specific images to use. It's possible, but very unlikely.
But do agree that it's not optimal that he's bashing CBD right next to our logo. But overall, put our image up there as much as possible! It designates us as the authority.
And he'll be exposed more and more as his bias becomes more evident.
Good question. I'm not sold on CVSI's sales operation to actually land huge accounts where the brand itself stands out. Sales is tough. CVSI is great at its product and industry reputation, but hopefully we see that they have a real sales team.
This stock is only about one thing now, as I've said before: Sales, sales, sales.
They can win all the awards they want - who cares - sales, sales, sales.
Competition is coming fast and hard, they better have the sales team to win.
Wrong - TRADERS need news for short term moves. Investors sit tight with a company that they believe in.
And most day traders lose money (though they'll never admit it).
Be an investor, not a trader.
Yep you're right. The one wrinkle is that they seem to be in the UK so not sure how that works. But if they are marketing in the US with that brand, based on my experience, they would be in violation of CVSI's mark.
You should email this to the company. They need to enforce their mark.
Curious: Which company is using CBD+ that's not CVSI?
AP - I think you mean "Trademark," not "Copyright" ? Trademarks and copyrights are very different things.
Who's copyright or trademark would they be violating? Can you please elaborate more on which you are talking about?
This stock price is going to do a whole lot of nothing until next earnings unless NASDAQ is announced or CA passes etc.
I'm excited for where we will hopefully be by the end of the year.
I hope FDA creates strict guidelines that CVSI will obviously meet and then heavily enforces makers and distributors of all the CRAP CBD stuff out there.
Bought more today. In two years today won't matter.
Relax - this company and this industry is still in its infant stages. Company, FDA and industry needs 6-24 months to work through all the machinations of adding this stuff to food, guidelines for preparing, etc.
Anyone here without money to lose shouldn't be here. If you NEED your money that's in CVSI, you should have never put it here. Go put it in Hershey's and Microsoft.
Companies like this on OTC are highly volatile and if you aren't prepared for that you are too inexperienced to be here or you need to learn what you are investing in.
When investing on OTC, and all the bullshit that comes with OTC, you are not investing in simply a company. You are investing in the OTC, the company, the emerging industry as a whole and the future framework of the industry.
This is an exciting company, but everyone needs to chill out.
And shut up about the PR stuff. This company does great PR when it warrants it.
The factors that are going to move this stock up past $6 are:
Sales, sales, sales
Some FDA movement on a more permanent regulatory framework
Buyout
The company should not be focused on profit. They should be focused on revenue. For their seeming ambition, profit at such an early stage can be a bad indicator that they haven't spent enough time or money to build out their sales funnel.
What it tells me is that they don't have the expertise or know-how to actually spend their money to increase sales at a continually faster pace - yet.
And with the marketplace gaining validity and their appearance in CVS - regardless of actual logistics or order sizes, slowing growth with all these good industry markers is going to crush this stock.
Don't make excuses and say "even a slowdown in sales."
You're hedging your psychological fear with that comment.
This is a very small, young company in a ridiculously huge wellness industry.
They better show big, growing growth.
And hopefully with their earnings, they will prove they have improved their sales funnels and my comments above will be moot.
"No one" ? Shows your inexperience in global M&A.
Hush now, troll.
Sales - plain and simple. Any slowness in growth in the next earnings report is going to tank this stock price.
At this point, no one cares if they have the "most pure" product - it's all about sales.
This isn't feel good rah-rah emotional support club.
Show us the money. Period.
This is big boy pants times. If the company is as exciting as everyone claims - the sales increase will be dramatic. It has to be.
This is not a big company - they can get wiped out easily by competitors with better marketing or larger distribution deals.
I'm hoping for a large distribution deal announcement or a buy out.
I agree. They seem to be getting left behind unless they have something big in the works.
But this is bad. No one cares if you're the industry-insider #1 super sourced etc. They pick whatever has the best branding and packaging and is in front of their face.
Maybe they are focusing on online sales only? Definitely much larger margins.
But I agree - it is not a good sign we aren't in all these stores.
I've been absent traveling and working, but wow this is great! Space Lady, do you want to take over my google doc of order tracking? I simply haven't had the time. It's pretty good so far though. Just needs some updating.
So you are just guessing based off what you want to be thinking?
When stocks are oversold, one typically analyzes market volume and the prices of shares moving over a duration where there is volatility.
With the huge run up the past two weeks one could also, argue from their gut, that the stock was overbought.
Without numbers or analysis, it's just guessing and wishful thinking one way or another.
"Way oversold"...based on what numbers or activity? Please list the numbers you used to determine that it's "way oversold."
*Nods head in agreement*. IF one can maintain the discipline to not get too greedy. Discipline, discipline, discipline.
Not that I believe Dupont is working with CVSI, however, I have a friend who owns a company that works with Dupont in a similar capacity as suggested here about CVSI. Your assessment on their decision making and potential scenarios is uninformed and ignorant, at best.
You clearly haven't been inside any large-cap company because if you had been, you'd know that this trademark scenario could easily 100% happen.
You suffer from thinking big companies and "higher-level" are so much more competent and that is a youthful misnomer from those that have never seen these things up close.
It's frustrating to me too! But these articles are:
1. Better than the previous "bad articles"
2. Normal for an emerging growth company with, in reality, a guy with a checkered past who was previously at the helm - people are going to take their shots
3. Inconsequential in the long-run if CVSI keeps performing with its sales
I go days at a time without looking at the SP now and it really doesn't matter much. The swings are big as a % but just keep thinking about 3 years from now (they'll probably be bought out IMO)
Does Google and Facebook respond to every single article about them? No. They do it in measured, appropriate venues, when the need arises.
Relax. Did you over-leverage yourself and now you need the SP to go up fast or something?
You are too anxious about all of this on a day-to-day basis.
Do you want to explain your trading philosophy a little so we know where you are coming from?
NASDAQ uplisting thoughts changing a little: I have been of the mind that a NASDAQ uplsting would not skyrocket CVSI up very quickly but seeing the SP run up of of virtually every other CBD/Hemp stock the past few months has me thinking maybe I'm naive.
If CVSI gets uplisted, with their numbers, their growth, their name recognition, I'm thinking this thing runs up 300% in the following 3-6 months.
I think the institutional investors are waiting for the NASDAQ green light of approval along with some other speculative investors.
OTC is too unguarded for the heavy investors to start loading up.
The more I see the continued runups of other CBD/Hemp stocks, the more I think CVSI will explode if uplisted to NASDAQ.